Table 1.
Conditions | Inheritance | Gene | Myotonia | Episodic weakness | Fixed weakness | Major trigger | Other features |
---|---|---|---|---|---|---|---|
DM | |||||||
DM type 1 | AD | DMPK | M | Absent | Distal limbs, face | None | Frontal balding, temporal wasting, cataracts, systemic disease |
Myotonic dystrophy type 2 (PROMM) | AD | CNBP (ZNF9) | M | Absent* | Proximal limbs | None | Disabling and atypical pain, cataracts, milder systemic disease |
NDM | |||||||
MC | |||||||
AD (Thomsen) | AD | CLCN1 | M | Absent | Rare | Rest | Generalized muscle hypertrophy |
AR (Becker) | AR | CLCN1 | M | Absent* | Proximal LE | Rest | Muscle hypertrophy in LE |
PMC | AD | SCN4A | P | Present in some | Proximal LE | Cold, exercise | Most sensitive to cold |
Potassium-sensitive periodic paralysis | AD | SCN4A | P, M or absent | Present | Proximal LE | K+, rest after exercise | Potassium levels may be high*** |
PAM | |||||||
Myotonia fluctuans | AD | SCN4A | M** | Absent | Absent | K+, exercise | Have good days and bad days |
Myotonia permanens | AD | SCN4A | M** | Absent | Absent | K+, exercise | Continuous muscle stiffness |
Acetazolamide-responsive myotonia | AD | SCN4A | M** | Absent | Absent | K+, exercise | Respond to therapy with acetazolamide |
AD: Autosomal dominant; AR: Autosomal recessive; K+: Potassium, LE: Lower extremities; M: Myotonia; P: Paramyotonia; PROMM: Proximal myotonic myopathy; DM: Dystrophic myotonias
PROMM patients may initially have intermittent or transient weakness; recessive MC patients may have transient weakness after severe bouts of stiffness,
May have eyelid paramyotonia,
Potassium levels may be normal during attack normokalemic periodic paralysis (normoKPP).